Browse Related Topics For:

Pharmaceutical Industry

810
Prescription Drugs
753
Patents
671
FDA
510
Pharmaceutical Patents
445
Patent Litigation
415
Generic Drugs
339
Patent Infringement
283
Medical Devices
256
Healthcare
226
ANDA
224
Biosimilars
193
SCOTUS
191
Biotechnology
144
Hatch-Waxman
140
Popular
136
FTC
131
Manufacturers
126
Off-Label Promotion
120
CMS
114
HHS
114
Medicare
110
Pharmacies
109
BPCIA
108
Physicians
105
Health Care Providers
101
Biologics
98
China
97
Medicaid
93
Affordable Care Act
92
Hospitals
90
FDCA
89
Drug Pricing
88
Section 340B
87
False Claims Act (FCA)
87
Life Sciences
83
DOJ
80
Claim Construction
77
Sandoz
74
First Amendment
73
Compliance
73
Off-Label Use
72
EU
70
Preemption
69
FDA Approval
68
Amgen
67
Actavis Inc.
67
Clinical Trials
67
Labeling
67
Teva Pharmaceuticals
66
Enforcement Actions
65
Reverse Payment Settlement Agreements
61
FTC v Actavis
61
HRSA
60
Inter Partes Review Proceedings
59
Class Action
59
USPTO
58
Antitrust Litigation
58
Marketing
58
OIG
58
Sandoz v Amgen
58
Sunshine Act
57
Appeals
57
Novartis
57
Pay-For-Delay
57
Teva v Sandoz
55
Failure To Warn
55
GlaxoSmithKline
52
Patent-Eligible Subject Matter
52
SEC
51
Advertising
51
De Novo Standard of Review
51
Mylan Pharmaceuticals
51
Patent Trial and Appeal Board
50
Clear Error Standard
50
FCPA
48
Draft Guidance
48
Pfizer
46
Infringement
46
Obviousness
45
Amarin
45
Medicare Part D
45
Orphan Drugs
44
Anti-Kickback Statute
44
Corporate Counsel
44
Federal Rules of Civil Procedure
44
Preliminary Injunctions
42
Australia
42
PHRMA
41
Prior Art
41
Reporting Requirements
41
Settlement
39
AstraZeneca
39
Whistleblowers
38
Apotex
38
Misbranding
38
Warning Labels
37
Bribery
37
Free Speech
36
Medical Research
36
UK
34
Civil Monetary Penalty
34
Patent-in-Suit
32
Comment Period
32
Drug Compounding
32
Drug Safety
32
Health Insurance
31
Covered Entities
31
Fraud
31
Hart-Scott-Rodino Act
31
Merck
31
Patent Applications
30
Bayer
30
Disclosure Requirements
30
Research and Development
29
Design Defects
28
Criminal Prosecution
28
Multidistrict Litigation
28
Negligence
28
Personal Jurisdiction
28
Proposed Regulation
27
America Invents Act
27
Eli Lilly
27
Qui Tam
27
Trademarks
26
AbbVie
26
Commercial Speech
26
DNA
26
GPOs
26
Healthcare Facilities
26
Patent Dance
26
Pending Legislation
25
EPA
25
Proposed Legislation
24
Enforcement
24
False Advertising
24
Johnson & Johnson
24
Summary Judgment
24
Watson Pharmaceuticals
23
Causation
23
Kickbacks
23
Product Labels
22
Biologics Price Competition and Innovation Act of 2009
22
Cancer
22
Gilead Sciences
22
Legislative Agendas
22
Patent Invalidity
21
Abbott Laboratories
21
Acquisitions
21
Anti-Competitive
21
Antitrust Provisions
21
Competition
21
Declaratory Judgments
21
Dismissals
21
Final Rules
21
Jurisdiction
21
Notice Requirements
21
PLIVA v Mensing
21
Safe Harbors
20
Drug & Alcohol Abuse
20
Healthcare Reform
20
Licenses
20
Patent Reform
20
Sherman Act
19
Birth Defects
19
Expert Testimony
19
Hazardous Waste
19
HIPAA
19
Learned Intermediary
19
Social Media
19
Standing
19
Transparency
18
Bristol-Myers Squibb
18
Canada
18
Commercial Marketing
18
Discovery
18
Innovation
18
License Agreements
18
Mergers
18
New Guidance
18
NIH
18
Opioid
18
Public Comment
17
Allergan Inc
17
Anti-Corruption
17
Caronia
17
Chief Compliance Officers
17
DaimlerChrysler v Bauman
17
European Commission
17
FFDCA
17
Hospira
17
Insider Trading
17
Intellectual Property Protection
17
Janssen Pharmaceuticals
17
Misrepresentation
17
Mutual Pharmaceuticals v Bartlett
17
Prescription Drug Coverage
17
Product Hopping
17
Professional Conferences
17
White Collar Crimes
16
Audits
16
DEA
16
Healthcare Fraud
16
Insurance Industry
16
Medicare Part B
16
Motion to Dismiss
16
New Legislation
16
Patients
16
RCRA
16
Side Effects
16
Trade Secrets
16
Trans-Pacific Partnership
16
Wrongful Death
15
Antitrust Investigations
15
Biopharmaceutical
15
Ethics
15
Lanham Act
15
Omnicare
15
Product Defects
15
Public Health Service Act
15
Takeda Pharmaceuticals
14
AMP v Myriad
14
CAFA
14
Cephalon
14
Class Certification
14
Corruption
14
Data Protection
14
Disgorgement
14
Government Investigations
14
Imports
14
Innovator Liability
14
Intellectual Property Litigation
14
Medical Malpractice
14
Myriad
14
Open Payments
14
Orange Book
14
Pleading Standards
14
Public Health
14
Strict Liability
14
Technology
14
Unfair Competition
13
Administrative Procedure Act
13
Cybersecurity
13
DSCSA
13
Fee-for-Service
13
Genetic Materials
13
Mayo v. Prometheus
13
Par Pharmaceutical
13
Social Networks
13
Wyeth
12
aBLA
12
Attorney Generals
12
Congressional Investigations & Hearings
12
Damages
12
DQSA
12
Hedge Funds
12
Omnicare v Laborers District Council
12
Personalized Medicine
12
Pregnancy
12
Section 11
12
Securities Fraud
12
Supply Chain
12
Warner Chilcott
11
21st Century Cures Initiative
11
Antitrust Violations
11
Automotive Industry
11
Citizen Petitions
11
Controlled Substances
11
Generic
11
IP License
11
Manufacturing Defects
11
MCOs
11
Medicare Advantage
11
Medtronic
11
Mental Health
11
Otsuka Pharmaceutical
11
Payment Records
11
Penalties
11
Post-Grant Review
11
Putative Class Actions
11
Relators
11
Scientific Research
11
Securities Act of 1933
11
Teaching Hospitals
11
Trade Agreements
11
World Health Organization
11
Yates Memorandum
10
3D Printing
10
CA Supreme Court
10
Co-payments
10
Dietary Supplements
10
Duty to Warn
10
En Banc Review
10
Evidence
10
Exclusivity
10
Expert Witness
10
Federal Contractors
10
Financial Sector
10
France
10
Genzyme
10
Inadequate Warning
10
India
10
Induced Infringement
10
Injunctions
10
Injunctive Relief
10
Material Misstatements
10
Ministry of Health
10
Misleading Statements
10
Nexium
10
Nurses
10
OMB
10
On-Sale Bar
10
OxyContin
10
Patent Term Adjustment
10
Professional Misconduct
10
Registration Statement
10
Russia
10
Technology Sector
10
Wholesale
9
Breach of Contract
9
Breach of Warranty
9
CDC
9
CHIP
9
Continuing Medical Education
9
Controlled Substances Act
9
Copyright
9
Department of Health
9
Diagnostic Tests
9
Distributors
9
Drug Distribution
9
Endo Pharmaceuticals
9
Exports
9
Final Guidance
9
Financial Conduct Authority (FCA)
9
Healthcare Costs
9
Illegal Drugs
9
Japan
9
Joint Venture
9
Mass Tort Litigation
9
Medical Supplies
9
Monopolization
9
Oil & Gas
9
Omnibus Guidance
9
PHI
9
Physician Medicare Reimbursements
9
Physician Payments
9
Private Equity
9
Public Disclosure
9
RanBaxy
9
Rebates
9
Regulatory Agenda
9
Rule-of-Reason Analysis
9
Sanctions
9
Sanofi-Aventis
9
Securities Litigation
9
Settlement Agreements
9
Shareholders
9
Software
9
Specific Jurisdiction
9
Strategic Enforcement Plan
9
Subject Matter Jurisdiction
9
Ukraine
9
Valeant
9
Venture Capital
8
Brand
8
Cartels
8
Chemicals
8
Defense Strategies
8
Drug Approvals
8
Durable Medical Equipment
8
First-to-File
8
Food Labeling
8
Foreign Corporations
8
Foreign Investment
8
Forum Shopping
8
Fraudulent Joinder
8
GAO
8
Genetic Testing
8
Good Faith
8
Google
8
Human Genes
8
Interpretive Rule
8
Legislative Committees
8
Managed Care Contracts
8
Private Right of Action
8
Product Exclusivity
8
Regulatory Standards
8
Remand
8
Reverse Payments
8
Rulemaking Process
8
Shareholder Litigation
8
Stark Law
8
Startups
8
Telemedicine
8
UK Brexit
8
USDA
8
Vaccinations
8
Warning Letters
8
Written Descriptions
8
Young Lawyers
8
Zoloft
7
Arbitration
7
BRCA
7
C-Suite Executives
7
CFDA
7
Clinical Laboratories
7
CLS Bank v Alice Corp
7
Corporate Integrity Agreement
7
Daubert Standards
7
Energy Sector
7
False Statements
7
FDA Warning Letters
7
Federal Budget
7
Food Manufacturers
7
General Jurisdiction
7
Hackers
7
Home Health Care
7
Informed Consent
7
Innovation Act
7
IRS
7
Jazz Pharmaceuticals
7
Jury Verdicts
7
Multinationals
7
Myriad-Mayo
7
Noninfringement
7
Petition for Writ of Certiorari
7
Premerger Notifications
7
Price-Fixing
7
Recordkeeping Requirements
7
Retailers
7
Royalties
7
Safe Drug Disposal
7
Scienter
7
Securities
7
Standard of Review
7
TRIPS Agreement
7
WTO
6
Adverse Events
6
AIDS
6
Banking Sector
6
Bayh-Dole Act
6
Celebrity Endorsements
6
Confidential Information
6
Corporate Culture
6
Corporate Taxes
6
Cost-Sharing
6
Covered Recipients
6
Cross-Border Transactions
6
Data Collection
6
Declaratory Relief
6
Diagnostic Method
6
Exclusive Dealing Agreements
6
Federal Register
6
FOIA
6
Guidance Update
6
Internal Controls
6
Inversion
6
Investors
6
Litigation Strategies
6
Martin Shkreli
6
Meals-Gifts-and Entertainment Rules
6
Medicaid Expansion
6
MedPAC
6
Merger Agreements
6
Mobile Apps
6
New Regulations
6
New Zealand
6
Patent Prosecution
6
Patent Trolls
6
Patient Assistance Programs
6
Patient Safety
6
Pharmaceutical Reverse Distributors
6
PHSA
6
Real Party in Interest
6
Registration Requirement
6
REMS
6
RICO
6
Risk Management
6
Securities Exchange Act
6
SFDA
6
Standard Essential Patents
6
Statement of Opinion
6
Substance Abuse
6
Suppliers
6
The Clayton Act
6
Trademark Infringement
6
Trademark Trial and Appeal Board
6
Unfair or Deceptive Trade Practices
6
Value-Based Purchasing
6
Websites
5
Abuse of Process
5
ACOs
5
Allergan v Sandoz
5
American Medical Association
5
Attorney's Fees
5
Attorney-Client Privilege
5
Auto Manufacturers
5
Aviation Industry
5
Barack Obama
5
Big Data
5
Biogen Idec
5
Burden of Proof
5
Certiorari
5
Choice-of-Law
5
Cipro
5
Classen Immunotherapies
5
Compensatory Damages
5
Competition Authorities
5
Conspiracies
5
Criminal Conspiracy
5
Cyber Attacks
5
Data Breach
5
Data Security
5
Data-Sharing
5
Dispute Resolution
5
Domestic Violence
5
Dormant Commerce Clause
5
EEA
5
Emerging Growth Companies
5
Enablement Inquiries
5
Environmental Policies
5
Federal Jurisdiction
5
Federal Rule 12(b)(6)
5
Financial Institutions
5
Financial Markets
5
Fines
5
Foreign Manufacturers
5
Foreign Official
5
Forest Laboratories
5
Genentech
5
Health Information Technologies
5
Health Insurance Exchanges
5
Hoffman LaRoche
5
Initial Public Offerings
5
International Harmonization
5
Internet
5
Inventions
5
Inventors
5
IPO
5
Joinder
5
Jury Instructions
5
Kim Kardashian
5
Likelihood of Confusion
5
Lipitor
5
Medical Marijuana
5
Medical Reimbursement
5
Negligent Misrepresentation
5
No-AG Agreement
5
Nursing Homes
5
OFAC
5
Online Advertisements
5
OPDP
5
Overpayment
5
Pain Management
5
PATENT Act
5
Patent Term Extensions
5
Permanent Injunctions
5
Product Recalls
5
Provider Payments
5
Publicly-Traded Companies
5
Punitive Damages
5
Radiopharmaceuticals
5
Regulatory Oversight
5
Reimbursements
5
Removal
5
Risk Assessment
5
Roxane Laboratories
5
Section 101
5
Third-Party
5
Trade Agreements Act
5
Twombly/Iqbal Pleading Standard
5
UK Bribery Act
5
UK Competition and Markets Authority (CMA)
5
Unions
5
Vendors
5
Veterinary Products
5
Yahoo!
4
Abuse of Dominance
4
Acquittals
4
Administrative Proceedings
4
Admissible Evidence
4
Advisory Committee
4
Aerospace
4
Alzheimer's
4
Amicus Briefs
4
Anti-Bribery
4
Anti-Monopoly
4
Antibiotics
4
Antitrust Conspiracies
4
Antitrust Division
4
Antitrust Injuries
4
Applicable Manufacturers
4
Ascertainable Class
4
Australian Patent Office
4
Black Box Warnings
4
Board of Directors
4
Cardinal Health
4
Chevron Deference
4
Commerce Clause
4
Compulsory Licenses
4
Consent Order
4
Construction Industry
4
Consumer Fraud
4
Corporate Governance
4
Cross-Border
4
Deferred Prosecution Agreements
4
Department of Transportation (DOT)
4
Department of Veterans Affairs
4
Derivative Suit
4
Disclosure
4
Diversity Jurisdiction
4
Duty of Care
4
Duty to Deal
4
E-Commerce
4
EHR
4
Elder Abuse
4
Employer Group Health Plans
4
EU-US Privacy Shield
4
FBI
4
FINRA
4
Food Safety
4
Forum
4
Forum Non Conveniens
4
FRAND
4
Fraud and Abuse
4
FTC Act
4
Funding
4
Germany
4
Global Marketplace
4
Hazardous Substances
4
HITECH
4
Interlocutory Injunctions
4
InterMune
4
International Arbitration
4
ITC
4
Kaiser Permanente
4
Kimble v Marvel Enterprises
4
Licensing Rules
4
Long Term Care Facilities
4
Marijuana
4
Material Nonpublic Information
4
Medicaid Reimbursements
4
Medical Records
4
Mensing
4
Mexico
4
Monsanto
4
Mortgages
4
NDRC
4
Negotiations
4
Nutritional Supplements
4
Obama Administration
4
OCR
4
OECD
4
Outsourcing
4
Patent Portfolios
4
Patient Privacy Rights
4
PDUFA
4
Pension Funds
4
Pharmaceutical Distribution
4
Pharmacist
4
Pleadings
4
Pre-Merger Filing Requirements
4
Prejudgment Interest
4
Premarket Approval Applications
4
Presidential Elections
4
Privacy Laws
4
Proximate Cause
4
Public Meetings
4
Public Offerings
4
Public Use
4
Referendums
4
Samsung
4
Sealed Records
4
Secretary of HHS
4
Section 2
4
Shareholder Activism
4
Shire Development v Watson
4
Skilled Nursing Facility
4
SmithKline Beecham
4
Software Developers
4
Solid Waste
4
Statute of Limitations
4
Stem cells
4
Stocks
4
STRONG Patents Act
4
Subpoenas
4
Tariffs
4
TCPA
4
Telehealth
4
Trade Relations
4
Trademark Registration
4
TTIP
4
UAW
4
Universities
4
Vacated
4
Viagra
4
Wage and Hour
3
23andMe
3
510(k) RTA
3
Actos
3
Africa
3
Ambry
3
Amended Legislation
3
Anticompetitive Agreements
3
Apple
3
Article III
3
Asbestos
3
Australian Competition and Consumer Commission
3
Australian Medical Association
3
AZ Supreme Court
3
Ballot Measures
3
Bank of America
3
Banks
3
BIS
3
Boehringer
3
Cadence Pharmaceuticals Inc.
3
Calculation of Damages
3
Cease and Desist Orders
3
CEOs
3
CGMP
3
China FDA
3
Clean Water Act
3
Clear and Convincing Evidence
3
Code of Conduct
3
Collective Bargaining
3
Columbia
3
Commercial Bankruptcy
3
Commercial General Liability Policies
3
Confidentiality Agreements
3
Conflicts of Interest
3
Consent
3
Consumer Product Safety Commission (CPSC)
3
Contraceptive Coverage Mandate
3
Contraceptives
3
Contract Disputes
3
Conversion
3
Cooperation
3
Cosmetics
3
Counterclaims
3
Counterfeit Drugs
3
Country of Origin
3
Coupons
3
Covered Business Method Patents
3
CVS
3
Daiichi Sankyo
3
Dairy Farmers
3
Data Privacy
3
Databases
3
Daubert Hearing
3
Daubert Ruling
3
DE Supreme Court
3
Defense Sector
3
Digital Health
3
Direct Infringement
3
Discount Pricing
3
Discounts
3
Dismissal With Prejudice
3
DMEPOS
3
Doctrine of Equivalents
3
Drug Testing
3
Due Diligence
3
Due Process
3
E-Cigarettes
3
Ebola
3
EEOC
3
EFTA
3
Elan Pharmaceuticals
3
Electronic Communications
3
Essential Drug List
3
EU Single Market
3
European Court of Justice (ECJ)
3
Exemptions
3
Expectation Damages
3
Failure To State A Claim
3
Fair Work Commission
3
FDASIA
3
Federal Funding
3
Federal Supply Schedule (FSS)
3
Fee-Shifting
3
Fiduciary Duty
3
Fifth Amendment
3
First-to-Invent
3
Foreign Subsidiaries
3
Fresenius
3
Genetic Markers
3
Global Economy
3
Good Clinical Practices
3
Governor Baker
3
Halliburton
3
Health Safety
3
Hepatitis C
3
Hiring & Firing
3
HIV
3
Hospice
3
Human Genome Project
3
Individual Accountability
3
Influenza
3
Inspections
3
Inter Partes Reexamination
3
Internal Investigations
3
International Data Transfers
3
Interstate Commerce
3
Investigations
3
Irreparable Harm
3
JAMA
3
Jury Awards
3
Law Enforcement
3
Limelight v Akamai
3
Litigation Hold
3
Local Ordinance
3
Markman Hearing
3
Media
3
Medicaid Reform
3
Medical Equipment
3
Middle East
3
Misleading Impressions
3
Mobile Devices
3
MOFCOM
3
Mootness
3
Motion for Reconsideration
3
Motion for Summary Judgment
3
NAFTA
3
Nanomaterials
3
Nanotechnology
3
National Emissions Standards
3
Native American Issues
3
Nautilus Inc. v. Biosig Instruments
3
Nike
3
Non-Disclosure Agreement
3
Online Drug Sales
3
openFDA
3
OPPS
3
Over-the-Counter Sales
3
Pain Management Clinics
3
Patent Assertion Entities
3
Personal Liability
3
Physician Fee Schedule
3
Physician Gift-Ban Law
3
POM Wonderful
3
POM Wonderful v Coca Cola
3
Price Manipulation
3
Prior Express Consent
3
Privacy Policy
3
PSLRA
3
Public Health Insurance Marketplace
3
Public Officials
3
Purple Book
3
Qualcomm
3
RAND
3
Red Notices
3
Reissue Patents
3
Research Funding
3
Reversal
3
Risk Mitigation
3
Robinson-Patman Act
3
Rule 9(b)
3
Sequenom
3
South Korea
3
Split of Authority
3
Sponsors
3
Stare Decisis
3
Supplementary Protection Certificate
3
Surveys
3
Tax Credits
3
The Common Rule
3
Third-Party Relationships
3
Toxic Exposure
3
Trademark Litigation
3
Transfers
3
TRICARE
3
Twitter
3
U.S. Commerce Department
3
Unified Patent Court
3
USTR
3
Validity
3
Valuation
3
Veterinarians
3
Vital Pharmaceuticals
3
Walgreens
3
Whistleblower Awards
3
Whistleblower Protection Policies
2
AARP
2
Aboriginal Issues
2
Abuse of Discretion
2
Acceleration
2
Actual Injuries
2
Additive Manufacturing
2
Administrative Appeals
2
Administrative Authority
2
Administrative Remedies
2
Advance Notice
2
Advisory Opinions
2
Affirmative Defenses
2
AIFMD
2
Algorithmic Trading
2
Alien Tort Statute
2
ALJ
2
Amended Complaints
2
Amended Regulation
2
American Hospital Association
2
Animal Testing
2
Annual Reports
2
Anti-SLAPP
2
Anticompetitive Behavior
2
Applications
2
Ariosa
2
Asbestos Litigation
2
Asia
2
Asia Pacific
2
Assignments
2
Avandia
2
Avon
2
Beneficiaries
2
BEPS
2
Bid Rigging
2
Bifurcation
2
Bilateral Investment Treaties
2
Billing
2
Biometric Information
2
Bipartisan Agreement
2
Bodily Injury
2
Bowman v Monsanto
2
Brazil
2
Broadcasting
2
Bundled Payments
2
Buyouts
2
CAFC
2
Capital Raising
2
Cartwright Act
2
Center for Drug Evaluation and Research (CDER)
2
Charitable Organizations
2
Charles Grassley
2
Children's Products
2
Claim Preclusion
2
Class Members
2
Clean Air Act
2
Clean Power Plan
2
Clinical Laboratory Testing
2
Cloud Computing
2
CME
2
Co-Op
2
Combination Products
2
Common Ownership
2
Community Health Systems
2
Competition Act
2
Complex Litigation
2
Comptroller
2
Computer Fraud and Abuse Act (CFAA)
2
Computer-Related Inventions
2
Congressional Committees
2
Consent Decrees
2
Consumer Protection Act
2
Contingency Fees
2
Contract Negotiations
2
Contract Term
2
Copyright Infringement
2
Corrective Actions
2
Counterfeiting
2
Covered Business Method Proceedings
2
Credibility
2
Creditors
2
Criminal Investigations
2
Crowdfunding
2
Customs
2
Customs and Border Protection
2
Cyber Crimes
2
Cybor Corp v FAS Technologies
2
DaimlerAG
2
Data Brokers
2
Data Integrity
2
Data Protection Authority
2
Data Theft
2
Debit and Credit Card Transactions
2
Debt Ceiling
2
Defense Contracts
2
Delays
2
Dental Practice
2
Dentists
2
Depositions
2
DHS
2
Directed Verdicts
2
Disciplinary Proceedings
2
Disclaimers
2
Discrimination
2
Discussion Draft
2
Divisional Applications
2
DOL
2
Double Patent
2
Drug Trafficking
2
Drug Wholesaling
2
Duty to Defend
2
eBay
2
Economic Development
2
Electronic Records
2
Electronically Stored Information
2
Email
2
Emerging Markets
2
Employer Liability Issues
2
Employment Contract
2
End-of-Life-Care
2
Energy Policy